05:59 PM EDT, 09/19/2024 (MT Newswires) -- Andrew Guggenhime, PRESIDENT AND CFO, on September 18, 2024, sold 8,000 shares in Vaxcyte ( PCVX ) for $927,551. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 90,383 shares of the company, with 90,383 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000164909424000071/xslF345X05/wk-form4_1726782498.xml